Clinical Trials Directory

Trials / Sponsors / CSL Limited

CSL Limited

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
CompletedA Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission
Leukemia, Myeloid, Acute
Phase 12012-07-01
CompletedA Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density L
Stable Atherothrombotic Disease
Phase 22012-02-01
CompletedA Multiple Ascending Dose Study of CSL112 in Healthy Volunteers
Healthy
Phase 12011-01-01
CompletedSafety, Tolerability and Pharmacokinetics of CSL112 in Healthy Volunteers
Healthy
Phase 12010-06-01
CompletedSafety Study of Subcutaneous Ig NextGen 16% in Patients With Primary Immunodeficiency
Primary Immune Deficiency
Phase 32008-04-01
CompletedIg NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients
Idiopathic Thrombocytopenic Purpura (ITP)
Phase 32007-06-01
CompletedIg NextGen 10% in Patients With Primary Immune Deficiency (PID)
Primary Immune Deficiency (PID)
Phase 32007-05-01
CompletedSubcutaneous Ig NextGen 16% in PID Patients
Primary Immunodeficiency (PID)
Phase 32007-04-01
CompletedSafety, Tolerability and Pharmacokinetics of CSL360 in the Treatment of Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML)
Phase 12006-12-01
CompletedEffect of rHDL on Atherosclerosis - Safety and Efficacy: THE ERASE TRIAL
Acute Coronary Syndromes
Phase 22005-07-01